Fieldpoint Private Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fieldpoint Private Advisors's PFE Position: Q3 2017 in Review
Fieldpoint Private Advisors sold out of Pfizer (PFE) in Q3 2017, closing a stake of 1,823 shares — an estimated $58K sold.
Fieldpoint Private Advisors first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $3.58M in Q2 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.
- Fieldpoint Private Advisors reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
- Fieldpoint Private Advisors sold 1,823 Pfizer shares in Q3 2017, an estimated $58K.
- Fieldpoint Private Advisors first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
- Fieldpoint Private Advisors's Pfizer position peaked at $3.58M in Q2 2016.
- 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.
Based on Fieldpoint Private Advisors's 13F filing for Q3 2017.